• Mon. Jul 4th, 2022

Dimancherouge

Technology

Disease

  • Home
  • Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities

Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities

 

Cheaper refrigerators? Stronger hip implants? A better understanding of human disease? All of these could be possible — ScienceDaily

 

Study finds fungal disease of snakes in 19 states, Puerto Rico — ScienceDaily

 

Using Machine Learning To Predict Disease In Cattle Might Help Solve A Billion-Dollar Problem

 

Researchers use multi-ancestry comparison to refine risk factors for coronary artery disease — ScienceDaily

 

PQ Bypass Completes Enrollment in DETOUR2 Percutaneous Femoral-Popliteal Bypass Pivotal Study for Patients With Complex Peripheral Arterial Disease

 

Personalized cancer therapy improves outcomes in advanced disease — ScienceDaily

 

Researchers demonstrate how changing the stem cell response to inflammation may reverse periodontal disease — ScienceDaily

 

Trump seemed to defy the laws of science and disease. Then, the coronavirus caught up with him.

 

People with Parkinson’s disease have a higher risk of dying from COVID-19 — ScienceDaily